|
Volumn 14, Issue 5, 1996, Pages 64-X
|
Affinity chromatography: Production and regulatory considerations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NUCLEIC ACID;
PLASMA PROTEIN;
PLASMINOGEN;
PYROGEN;
RECOMBINANT PROTEIN;
AFFINITY CHROMATOGRAPHY;
ARTICLE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FOOD AND DRUG ADMINISTRATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
ISOLATION AND PURIFICATION;
LEGAL ASPECT;
MASS SPECTROMETRY;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
ORGANIZATION AND MANAGEMENT;
THERAPY;
THIN LAYER CHROMATOGRAPHY;
UNITED STATES;
BLOOD PROTEINS;
CHROMATOGRAPHY, AFFINITY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CHROMATOGRAPHY, THIN LAYER;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
MAGNETIC RESONANCE SPECTROSCOPY;
MASS SPECTROMETRY;
NUCLEIC ACIDS;
PLASMINOGEN;
PYROGENS;
RECOMBINANT PROTEINS;
THERAPEUTICS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0030115321
PISSN: 07493223
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (13)
|